Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2012

01.08.2012 | Review Article

Preneoplastic conditions underlying bile duct cancer

verfasst von: Lena Sibulesky, Justin Nguyen, Tushar Patel

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Malignancies arising from the biliary tract can arise from the epithelial lining of the biliary tract and surrounding tissues. Conditions that predispose to malignancy as well as preneoplastic changes in biliary tract epithelia have been identified. In this overview, we discuss preneoplastic conditions of the biliary tract and emphasize their clinical relevance.

Results

Chronic biliary tract inflammation predisposes to cancer in the biliary tract. Biliary tract carcinogenesis involves a multistep process as a consequence of chronic biliary epithelial injury or inflammation. Reminiscent of other gastrointestinal epithelial malignancies such as gastric, colon, and pancreatic cancer, biliary tract cancers may evolve via multistep progression from epithelial hyperplasia and dysplasia to malignant transformation. The potential role of initiating cells is also becoming recognized.

Conclusions

In spite of improved risk factor recognition, and advances in diagnostic tools, the early diagnosis of pre-malignant or malignant biliary tract conditions is extremely challenging, and there is a paucity of evidence on which to base their management. As a result, the role of pre-emptive surgery remains largely undefined.
Literatur
1.
Zurück zum Zitat Patel T Cholangiocarcinoma—controversies and challenges. Nat Rev Gastroenterol Hepatol 8 (4):189–200 Patel T Cholangiocarcinoma—controversies and challenges. Nat Rev Gastroenterol Hepatol 8 (4):189–200
2.
Zurück zum Zitat Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, Gaudio E, Alvaro D Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42 (4):253–260 Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, Gaudio E, Alvaro D Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 42 (4):253–260
3.
Zurück zum Zitat Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F Cholangiocarcinoma: a position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis 42 (12):831–838 Alvaro D, Cannizzaro R, Labianca R, Valvo F, Farinati F Cholangiocarcinoma: a position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Dig Liver Dis 42 (12):831–838
4.
Zurück zum Zitat Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48(1):308–321PubMedCrossRef Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48(1):308–321PubMedCrossRef
5.
Zurück zum Zitat Okuda K, Nakanuma Y, Miyazaki M (2002) Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 17(10):1049–1055PubMedCrossRef Okuda K, Nakanuma Y, Miyazaki M (2002) Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 17(10):1049–1055PubMedCrossRef
6.
Zurück zum Zitat Ben-Menachem T (2007) Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 19(8):615–617PubMedCrossRef Ben-Menachem T (2007) Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 19(8):615–617PubMedCrossRef
7.
Zurück zum Zitat Alvaro D, Bragazzi MC, Benedetti A, Fabris L, Fava G, Invernizzi P, Marzioni M, Nuzzo G, Strazzabosco M, Stroffolini T Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. Dig Liver Dis 43 (1):60–65 Alvaro D, Bragazzi MC, Benedetti A, Fabris L, Fava G, Invernizzi P, Marzioni M, Nuzzo G, Strazzabosco M, Stroffolini T Cholangiocarcinoma in Italy: a national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. Dig Liver Dis 43 (1):60–65
8.
Zurück zum Zitat Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38(4):610–615PubMedCrossRef Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38(4):610–615PubMedCrossRef
9.
Zurück zum Zitat Fevery J, Verslype C An update on cholangiocarcinoma associated with primary sclerosing cholangitis. Curr Opin Gastroenterol 26 (3):236–245 Fevery J, Verslype C An update on cholangiocarcinoma associated with primary sclerosing cholangitis. Curr Opin Gastroenterol 26 (3):236–245
10.
Zurück zum Zitat Klatskin G (1965) Adenocarcinoma of the hepatic duct at tts bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38:241–256PubMedCrossRef Klatskin G (1965) Adenocarcinoma of the hepatic duct at tts bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38:241–256PubMedCrossRef
11.
Zurück zum Zitat Charbel H, Al-Kawas FH Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep 13 (2):182–187 Charbel H, Al-Kawas FH Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep 13 (2):182–187
12.
Zurück zum Zitat Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10(2):77–82CrossRef Khan SA, Toledano MB, Taylor-Robinson SD (2008) Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 10(2):77–82CrossRef
13.
Zurück zum Zitat Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(6):VI1–9PubMedCrossRef Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Thursz MR, Wasan H (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(6):VI1–9PubMedCrossRef
14.
Zurück zum Zitat Tyson GL, El-Serag HB Risk factors for cholangiocarcinoma. Hepatology 54 (1):173–184 Tyson GL, El-Serag HB Risk factors for cholangiocarcinoma. Hepatology 54 (1):173–184
15.
Zurück zum Zitat Yu TH, Yuan RH, Chen YL, Yang WC, Hsu HC, Jeng YM. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression. Mod Pathol 24 (6):810–819 Yu TH, Yuan RH, Chen YL, Yang WC, Hsu HC, Jeng YM. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression. Mod Pathol 24 (6):810–819
16.
Zurück zum Zitat El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49(1):116–123PubMedCrossRef El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 49(1):116–123PubMedCrossRef
17.
Zurück zum Zitat Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ (2008) Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case–control study. Am J Gastroenterol 103(7):1716–1720PubMedCrossRef Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ (2008) Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case–control study. Am J Gastroenterol 103(7):1716–1720PubMedCrossRef
18.
Zurück zum Zitat Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case–control study. Clin Gastroenterol Hepatol 5(10):1221–1228PubMedCrossRef Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case–control study. Clin Gastroenterol Hepatol 5(10):1221–1228PubMedCrossRef
19.
Zurück zum Zitat Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA (2007) Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case–control study. Int J Cancer 120(3):638–641PubMedCrossRef Welzel TM, Mellemkjaer L, Gloria G, Sakoda LC, Hsing AW, El Ghormli L, Olsen JH, McGlynn KA (2007) Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case–control study. Int J Cancer 120(3):638–641PubMedCrossRef
20.
Zurück zum Zitat Jing W, Jin G, Zhou X, Zhou Y, Zhang Y, Shao C, Liu R, Hu X Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev 21 (1):24–31 Jing W, Jin G, Zhou X, Zhou Y, Zhang Y, Shao C, Liu R, Hu X Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev 21 (1):24–31
21.
Zurück zum Zitat Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol 34 (1):27–34 Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol 34 (1):27–34
22.
Zurück zum Zitat Zen Y, Aishima S, Ajioka Y, Haratake J, Kage M, Kondo F, Nimura Y, Sakamoto M, Sasaki M, Shimamatsu K, Wakasa K, Park YN, Chen MF, Atomi Y, Nakanuma Y (2005) Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int 55(4):180–188PubMedCrossRef Zen Y, Aishima S, Ajioka Y, Haratake J, Kage M, Kondo F, Nimura Y, Sakamoto M, Sasaki M, Shimamatsu K, Wakasa K, Park YN, Chen MF, Atomi Y, Nakanuma Y (2005) Proposal of histological criteria for intraepithelial atypical/proliferative biliary epithelial lesions of the bile duct in hepatolithiasis with respect to cholangiocarcinoma: preliminary report based on interobserver agreement. Pathol Int 55(4):180–188PubMedCrossRef
23.
Zurück zum Zitat Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, Hong SM, Hytiroglou P, Kloppel G, Lauwers GY, van Leeuwen DJ, Notohara K, Oshima K, Quaglia A, Sasaki M, Sessa F, Suriawinata A, Tsui W, Atomi Y, Nakanuma Y (2007) Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20(6):701–709PubMedCrossRef Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, Hong SM, Hytiroglou P, Kloppel G, Lauwers GY, van Leeuwen DJ, Notohara K, Oshima K, Quaglia A, Sasaki M, Sessa F, Suriawinata A, Tsui W, Atomi Y, Nakanuma Y (2007) Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 20(6):701–709PubMedCrossRef
24.
Zurück zum Zitat Rougemont AL, Genevay M, McKee TA, Gremaud M, Mentha G, Rubbia-Brandt L Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch 456 (6):711–717 Rougemont AL, Genevay M, McKee TA, Gremaud M, Mentha G, Rubbia-Brandt L Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch 456 (6):711–717
25.
Zurück zum Zitat Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC (2009) Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115(19):4564–4575PubMedCrossRef Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC (2009) Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 115(19):4564–4575PubMedCrossRef
26.
Zurück zum Zitat Jain D, Nayak NC Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers. J Clin Pathol Jain D, Nayak NC Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers. J Clin Pathol
27.
Zurück zum Zitat Nakanuma Y, Sasaki M, Sato Y, Ren X, Ikeda H, Harada K (2009) Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. World J Hepatol 1(1):35–42PubMedCrossRef Nakanuma Y, Sasaki M, Sato Y, Ren X, Ikeda H, Harada K (2009) Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. World J Hepatol 1(1):35–42PubMedCrossRef
28.
Zurück zum Zitat Shinozaki A, Shibahara J, Noda N, Tanaka M, Aoki T, Kokudo N, Fukayama M Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 459 (1):73–80 Shinozaki A, Shibahara J, Noda N, Tanaka M, Aoki T, Kokudo N, Fukayama M Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 459 (1):73–80
29.
Zurück zum Zitat Aishima S, Iguchi T, Fujita N, Taketomi A, Maehara Y, Tsuneyoshi M, Oda Y Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non-biliary aetiology. Histopathology 59 (5):867–875 Aishima S, Iguchi T, Fujita N, Taketomi A, Maehara Y, Tsuneyoshi M, Oda Y Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non-biliary aetiology. Histopathology 59 (5):867–875
30.
Zurück zum Zitat Nakanuma Y A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int 60 (6):419–429 Nakanuma Y A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int 60 (6):419–429
31.
Zurück zum Zitat Bickenbach K, Galka E, Roggin KK (2009) Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Surg Oncol Clin N Am 18(2):215–224, viiPubMedCrossRef Bickenbach K, Galka E, Roggin KK (2009) Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Surg Oncol Clin N Am 18(2):215–224, viiPubMedCrossRef
32.
Zurück zum Zitat Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99(3):523–526PubMedCrossRef Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99(3):523–526PubMedCrossRef
33.
Zurück zum Zitat de Valle MB, Bjornsson E, Lindkvist B Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int de Valle MB, Bjornsson E, Lindkvist B Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort. Liver Int
34.
Zurück zum Zitat Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36(3):321–327PubMedCrossRef Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzen H, Almer S, Granath F, Broome U (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36(3):321–327PubMedCrossRef
35.
Zurück zum Zitat Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E (2002) Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 37(10):1205–1211PubMedCrossRef Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E (2002) Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 37(10):1205–1211PubMedCrossRef
36.
Zurück zum Zitat Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand J Gastroenterol 32(10):1042–1045PubMedCrossRef Kornfeld D, Ekbom A, Ihre T (1997) Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study. Scand J Gastroenterol 32(10):1042–1045PubMedCrossRef
37.
Zurück zum Zitat Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD (2008) Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48(4):1106–1117PubMedCrossRef Charatcharoenwitthaya P, Enders FB, Halling KC, Lindor KD (2008) Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 48(4):1106–1117PubMedCrossRef
38.
Zurück zum Zitat Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP (2008) The challenges in primary sclerosing cholangitis—aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48(Suppl 1):S38–57PubMedCrossRef Weismuller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP (2008) The challenges in primary sclerosing cholangitis—aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 48(Suppl 1):S38–57PubMedCrossRef
39.
Zurück zum Zitat Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H (2000) Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case–control study. Hepatology 31(1):7–11PubMedCrossRef Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H (2000) Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case–control study. Hepatology 31(1):7–11PubMedCrossRef
40.
Zurück zum Zitat Bergquist A, Glaumann H, Persson B, Broome U (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case–control study. Hepatology 27(2):311–316PubMedCrossRef Bergquist A, Glaumann H, Persson B, Broome U (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case–control study. Hepatology 27(2):311–316PubMedCrossRef
41.
Zurück zum Zitat Razumilava N, Gores GJ, Lindor KD Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54 (5):1842–1852 Razumilava N, Gores GJ, Lindor KD Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54 (5):1842–1852
42.
Zurück zum Zitat Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA (2008) Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology 47(1):90–96PubMedCrossRef Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA (2008) Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology 47(1):90–96PubMedCrossRef
43.
Zurück zum Zitat de Martel C, Franceschi S (2009) Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70(3):183–194PubMedCrossRef de Martel C, Franceschi S (2009) Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70(3):183–194PubMedCrossRef
44.
Zurück zum Zitat Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, Brindley PJ (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4(7):e201PubMedCrossRef Sripa B, Kaewkes S, Sithithaworn P, Mairiang E, Laha T, Smout M, Pairojkul C, Bhudhisawasdi V, Tesana S, Thinkamrop B, Bethony JM, Loukas A, Brindley PJ (2007) Liver fluke induces cholangiocarcinoma. PLoS Med 4(7):e201PubMedCrossRef
45.
Zurück zum Zitat Watanapa P, Watanapa WB (2002) Liver fluke-associated cholangiocarcinoma. Br J Surg 89(8):962–970PubMedCrossRef Watanapa P, Watanapa WB (2002) Liver fluke-associated cholangiocarcinoma. Br J Surg 89(8):962–970PubMedCrossRef
46.
Zurück zum Zitat Tsui WM, Lam PW, Lee WK, Chan YK (2011) Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis: a tale of 3 countries. Adv Anat Pathol 18(4):318–28 Tsui WM, Lam PW, Lee WK, Chan YK (2011) Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis: a tale of 3 countries. Adv Anat Pathol 18(4):318–28
47.
Zurück zum Zitat Tsui WM, Chan YK, Wong CT, Lo YF, Yeung YW, Lee YW Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features. Semin Liver Dis 31 (1):33–48 Tsui WM, Chan YK, Wong CT, Lo YF, Yeung YW, Lee YW Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features. Semin Liver Dis 31 (1):33–48
48.
Zurück zum Zitat Todani T, Watanabe Y, Narusue M, Tabuchi K, Okajima K (1977) Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 134(2):263–269PubMedCrossRef Todani T, Watanabe Y, Narusue M, Tabuchi K, Okajima K (1977) Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 134(2):263–269PubMedCrossRef
49.
Zurück zum Zitat Singham J, Yoshida EM, Scudamore CH (2009) Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg 52(5):434–440PubMed Singham J, Yoshida EM, Scudamore CH (2009) Choledochal cysts: part 1 of 3: classification and pathogenesis. Can J Surg 52(5):434–440PubMed
50.
51.
Zurück zum Zitat Mabrut JY, Bozio G, Hubert C, Gigot JF Management of congenital bile duct cysts. Dig Surg 27 (1):12–18 Mabrut JY, Bozio G, Hubert C, Gigot JF Management of congenital bile duct cysts. Dig Surg 27 (1):12–18
52.
Zurück zum Zitat Lee SE, Jang JY, Lee YJ, Choi DW, Lee WJ, Cho BH, Kim SW Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg 146 (10):1178–1184 Lee SE, Jang JY, Lee YJ, Choi DW, Lee WJ, Cho BH, Kim SW Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea. Arch Surg 146 (10):1178–1184
53.
Zurück zum Zitat Ananthakrishnan AN, Saeian K (2007) Caroli's disease: identification and treatment strategy. Curr Gastroenterol Rep 9(2):151–155PubMedCrossRef Ananthakrishnan AN, Saeian K (2007) Caroli's disease: identification and treatment strategy. Curr Gastroenterol Rep 9(2):151–155PubMedCrossRef
54.
Zurück zum Zitat Mecklin JP, Jarvinen HJ, Virolainen M (1992) The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 69(5):1112–1114PubMedCrossRef Mecklin JP, Jarvinen HJ, Virolainen M (1992) The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma. Cancer 69(5):1112–1114PubMedCrossRef
55.
Zurück zum Zitat Kim JK, Hwang HK, Park JS, Cho SI, Yoon DS, Chi HS (2008) Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis. J Surg Oncol 98(2):139–142PubMedCrossRef Kim JK, Hwang HK, Park JS, Cho SI, Yoon DS, Chi HS (2008) Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis. J Surg Oncol 98(2):139–142PubMedCrossRef
56.
Zurück zum Zitat McLoughlin M, Enns R (2008) Endoscopy in the management of primary sclerosing cholangitis. Curr Gastroenterol Rep 10(2):177–185PubMedCrossRef McLoughlin M, Enns R (2008) Endoscopy in the management of primary sclerosing cholangitis. Curr Gastroenterol Rep 10(2):177–185PubMedCrossRef
57.
Zurück zum Zitat Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, Kim KA, Choi SY (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29(3):683–700PubMedCrossRef Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, Cho HJ, Kim KA, Choi SY (2009) Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 29(3):683–700PubMedCrossRef
58.
Zurück zum Zitat Morana G, Dorigo A Imaging of cholangiocarcinoma. Cancer Imaging 11:S72-73 Morana G, Dorigo A Imaging of cholangiocarcinoma. Cancer Imaging 11:S72-73
59.
Zurück zum Zitat Gotthardt D, Chahoud F, Sauer P Primary sclerosing cholangitis: diagnostic and therapeutic problems. Dig Dis 29 Suppl 1:41–45 Gotthardt D, Chahoud F, Sauer P Primary sclerosing cholangitis: diagnostic and therapeutic problems. Dig Dis 29 Suppl 1:41–45
60.
Zurück zum Zitat Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ Diagnosis and management of primary sclerosing cholangitis. Hepatology 51 (2):660–678 Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ Diagnosis and management of primary sclerosing cholangitis. Hepatology 51 (2):660–678
61.
Zurück zum Zitat Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R (2004) Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 99(3):502–508PubMedCrossRef Bjornsson E, Lindqvist-Ottosson J, Asztely M, Olsson R (2004) Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol 99(3):502–508PubMedCrossRef
62.
Zurück zum Zitat Barr Fritcher EG, Kipp BR, Voss JS, Clayton AC, Lindor KD, Halling KC, Gores GJ Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol 106 (11):2023–2028 Barr Fritcher EG, Kipp BR, Voss JS, Clayton AC, Lindor KD, Halling KC, Gores GJ Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Am J Gastroenterol 106 (11):2023–2028
63.
Zurück zum Zitat Van Beers BE (2008) Diagnosis of cholangiocarcinoma. HPB (Oxford) 10(2):87–93CrossRef Van Beers BE (2008) Diagnosis of cholangiocarcinoma. HPB (Oxford) 10(2):87–93CrossRef
64.
Zurück zum Zitat Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 41 (11):1558–1565 Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 41 (11):1558–1565
65.
Zurück zum Zitat Singham J, Yoshida EM, Scudamore CH Choledochal cysts. Part 3 of 3: management. Can J Surg 53 (1):51–56 Singham J, Yoshida EM, Scudamore CH Choledochal cysts. Part 3 of 3: management. Can J Surg 53 (1):51–56
66.
Zurück zum Zitat Kendrick ML, Nagorney DM (2009) Bile duct cysts: contemporary surgical management. Curr Opin Gastroenterol 25(3):240–244PubMedCrossRef Kendrick ML, Nagorney DM (2009) Bile duct cysts: contemporary surgical management. Curr Opin Gastroenterol 25(3):240–244PubMedCrossRef
67.
Zurück zum Zitat Cho MJ, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Lee SK, Kim MH, Lee SS, Park DH, Lee SG Surgical experience of 204 cases of adult choledochal cyst disease over 14 years. World J Surg 35 (5):1094–1102 Cho MJ, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Lee SK, Kim MH, Lee SS, Park DH, Lee SG Surgical experience of 204 cases of adult choledochal cyst disease over 14 years. World J Surg 35 (5):1094–1102
68.
Zurück zum Zitat Ulrich F, Pratschke J, Pascher A, Neumann UP, Lopez-Hanninen E, Jonas S, Neuhaus P (2008) Long-term outcome of liver resection and transplantation for Caroli disease and syndrome. Ann Surg 247(2):357–364PubMedCrossRef Ulrich F, Pratschke J, Pascher A, Neumann UP, Lopez-Hanninen E, Jonas S, Neuhaus P (2008) Long-term outcome of liver resection and transplantation for Caroli disease and syndrome. Ann Surg 247(2):357–364PubMedCrossRef
69.
Zurück zum Zitat Wiencke K, Boberg KM Current consensus on the management of primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol 35 (12):786–791 Wiencke K, Boberg KM Current consensus on the management of primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol 35 (12):786–791
70.
Zurück zum Zitat Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA (1999) Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30(5):1121–1127PubMedCrossRef Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, Poterucha JJ, Rosen CB, Gores GJ, LaRusso NF, Krom RA (1999) Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 30(5):1121–1127PubMedCrossRef
71.
Zurück zum Zitat Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40(5):815–822PubMedCrossRef Brandsaeter B, Isoniemi H, Broome U, Olausson M, Backman L, Hansen B, Schrumpf E, Oksanen A, Ericzon BG, Hockerstedt K, Makisalo H, Kirkegaard P, Friman S, Bjoro K (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40(5):815–822PubMedCrossRef
72.
Zurück zum Zitat Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E (2006) Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 45(4):568–574PubMedCrossRef Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E (2006) Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol 45(4):568–574PubMedCrossRef
73.
Zurück zum Zitat Maheshwari A, Yoo HY, Thuluvath PJ (2004) Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 99(3):538–542PubMedCrossRef Maheshwari A, Yoo HY, Thuluvath PJ (2004) Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 99(3):538–542PubMedCrossRef
74.
Zurück zum Zitat Tischendorf JJ, Geier A, Trautwein C (2008) Current diagnosis and management of primary sclerosing cholangitis. Liver Transpl 14(6):735–746PubMedCrossRef Tischendorf JJ, Geier A, Trautwein C (2008) Current diagnosis and management of primary sclerosing cholangitis. Liver Transpl 14(6):735–746PubMedCrossRef
75.
Zurück zum Zitat Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl 17 (11):1355–1363 Goldberg D, French B, Thomasson A, Reddy KR, Halpern SD Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl 17 (11):1355–1363
76.
Zurück zum Zitat Gores GJ, Gish RG, Sudan D, Rosen CB (2006) Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 12(12 Suppl 3):S95–97PubMedCrossRef Gores GJ, Gish RG, Sudan D, Rosen CB (2006) Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia. Liver Transpl 12(12 Suppl 3):S95–97PubMedCrossRef
77.
Zurück zum Zitat Rosen CB, Heimbach JK, Gores GJ Liver transplantation for cholangiocarcinoma. Transpl Int 23 (7):692–697 Rosen CB, Heimbach JK, Gores GJ Liver transplantation for cholangiocarcinoma. Transpl Int 23 (7):692–697
78.
Zurück zum Zitat Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242(3):451–458, discussion 458–461PubMed Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, Gores GJ, Nagorney DM (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242(3):451–458, discussion 458–461PubMed
79.
Zurück zum Zitat Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ (2009) Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 18(2):325–337, ixPubMedCrossRef Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ (2009) Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 18(2):325–337, ixPubMedCrossRef
80.
Zurück zum Zitat Carbone M, Neuberger J Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol 35 (6–7):446–454 Carbone M, Neuberger J Liver transplantation in PBC and PSC: indications and disease recurrence. Clin Res Hepatol Gastroenterol 35 (6–7):446–454
Metadaten
Titel
Preneoplastic conditions underlying bile duct cancer
verfasst von
Lena Sibulesky
Justin Nguyen
Tushar Patel
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2012
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-012-0943-7

Weitere Artikel der Ausgabe 6/2012

Langenbeck's Archives of Surgery 6/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.